TAILORING DRUG PRODUCT FORMULATIONS FOR ENHANCED BIOAVAILABILITY

The pharmaceutical industry is continuously striving to improve drug products that exhibit optimal bioavailability. Bioavailability refers to the fractional/proportionate/percentage of a drug that reaches the systemic circulation in its active form, influencing peptide synthesis machine its therapeutic efficacy. Formulating strategies play a crucia